Cel Sci (CVM) Net Equity Issued and Repurchased (2010 - 2026)
Cel Sci (CVM) reported Net Equity Issued and Repurchased of $2.2 million for fiscal Q3 2026 (quarter ended Jun 30, 2026).
Powered by 
Analysis
Cel Sci (CVM) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Cel Sci's Net Equity Issued and Repurchased came in at $17.93 million; for FY2025 (ended Sep 30, 2025), it was $28.29 million, up 20.0% from FY2024.
- Net Equity Issued and Repurchased has a five-year compound annual growth rate of 15.1% (FY2020 to FY2025).
- By fiscal year, Net Equity Issued and Repurchased came in at $23.58 million in FY2024 (+259.8%), $6.55 million in FY2023, $101,225 in FY2022 (-54.0%) and $220,000 in FY2021 (-98.4%).
- The fiscal Q3 2026 figure ranks as the lowest quarterly Net Equity Issued and Repurchased since fiscal Q2 2025.
- Year over year, Net Equity Issued and Repurchased gained in three of the last four quarters, with growth averaging 22.4%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Cel Sci | 3.69 Mn | -21.96 Mn | - | 9.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.70 Mn |
| Sep 30, 2025 | 15.73 Mn |
| Jun 30, 2025 | 5.00 Mn |
| Mar 31, 2025 | 2.56 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Sep 30, 2024 | 10.85 Mn |
| Mar 31, 2024 | 7.75 Mn |
| Dec 31, 2023 | 4.98 Mn |
| Sep 30, 2023 | 5.00 Mn |
| Jun 30, 2023 | 1.11 Mn |
| Dec 31, 2022 | 447,291.00 |
| Sep 30, 2022 | 101,225.00 |
| Jun 30, 2022 | -131,060.00 |
| Mar 31, 2022 | 13,860.00 |
| Dec 31, 2021 | 117,200.00 |
| Sep 30, 2021 | -47.14 Mn |
| Jun 30, 2021 | 60.92 Mn |
| Mar 31, 2021 | -27.12 Mn |
| Dec 31, 2020 | 13.56 Mn |
| Jun 30, 2020 | 1.07 Mn |
API Access
Cel Sci Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CVM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "CVM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CVM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();